Despite New Launches, Teligent Sees A Disappointing Q4
Company Cuts First-Quarter Projections Due To COVID-19
Amid poor quarterly results, Teligent continues to focus on resolving a warning letter from the FDA, passing a pre-approval inspection of its new injectables manufacturing facility in Buena, New Jersey and managing cash flow under its new CEO.
